A potential coronavirus vaccine in Cuba used to treat 58 patients, including those with severe and critical conditions from COVID-19, gave promising results, according to a Cuban expert.
The CIGB 258 vaccine has an 84% survival rate, Verena Muzio, chief of the Genetic Engineering and Biotechnology Center (CIGB), told the Mesa Redonda television program Wednesday.
Muzio said 72% of critically ill patients and 90% of severe cases recovered from the virus with the vaccine treatment.
Cuba has 2,107 coronavirus cases and 83 deaths, while recoveries neared the 2,000 marks, according to the data compiled by US-based Johns Hopkins University.
No comments:
Post a Comment